Related Experiment Videos
Prolactin response to dexamethasone: a study on normal controls and depressed patients
R Rupprecht1, A Barocka, E Jecht
1Department of Psychiatry, University of Erlangen-Nürnberg, West Germany.
Acta Psychiatrica Scandinavica
|August 1, 1987
Summary
Dexamethasone suppressed prolactin levels in depression patients and controls. This "prolactin suppression test" showed promise but was not specific for endogenous depression, highlighting altered endocrine axes in mood disorders.
Area of Science:
- Neuroendocrinology
- Psychiatry
- Endocrinology
Background:
- Depression is associated with alterations in endocrine axes.
- The dexamethasone suppression test (DST) is a standard diagnostic tool.
- Prolactin and cortisol levels are key endocrine markers.
Purpose of the Study:
- To investigate the effect of dexamethasone on prolactin and cortisol in depression.
- To evaluate a novel
- prolactin suppression test
- as a potential diagnostic marker for depression.
Main Methods:
- Studied pre- and post-dexamethasone prolactin and cortisol levels.
- Included 40 patients with endogenous and non-endogenous depression and 20 controls.
- Developed and compared a dexamethasone prolactin suppression test to the DST.
Main Results:
- Dexamethasone suppressed prolactin levels, with greater suppression in controls and non-endogenous depression compared to endogenous depression.
- The novel prolactin suppression test yielded results comparable to the DST.
- The prolactin suppression test lacked specificity for identifying endogenous depression.
Conclusions:
- Dexamethasone influences prolactin secretion in depression, but not specifically for endogenous subtypes.
- Altered relationships between endocrine axes may play a role in depression pathophysiology.
- Further research is needed to understand the neuroendocrine basis of depression.